Research at MD Anderson
Scroll Ahead
Research fuels our mission to end cancer
Many of the greatest minds in cancer research are at MD Anderson. They're here because MD Anderson offers a unique environment that accelerates their ability to end cancer. They collaborate with other cancer experts – in different research areas and with the world's leading cancer doctors. Bright students and trainees contribute further to our dynamic research environment. Discoveries are fueled by vast research support and resources. Tomorrow's medicine is available to our patients first since we have the most cancer clinical trials in the world. These research efforts work in parallel to fight cancer through prevention, early diagnosis, effective therapies and scientific breakthroughs.
CPRIT Funding Awards
$11M+
for multi-investigator research
$12M+
in support for core facilities
$4M
for new faculty recruitment
Learn more about MD Anderson’s CPRIT funding
Departments, Labs and Institutes
MD Anderson has many parts, including departments, labs and institutes, but the sum of those parts is ending cancer. MD Anderson's reach is comprehensive when it comes to eliminating cancer.
Research Areas
Since 1941, MD Anderson has been home to some of the brightest minds across a variety of cancer research areas.
Resources
MD Anderson provides research tools and resources to fuel the discoveries of our scientists.
Moon Shots Program
Inspired by an unprecedented era of scientific discovery a generation ago, the Moon Shots Program™ was launched by MD Anderson as an ambitious plan to make a giant leap in cancer research to benefit patients.
Learn more about the Moon Shots ProgramResearch Highlights
Nobel Prize Winner
Metastatic lung cancer
Neoadjuvant therapy
Pancreatic cancer
Metastasis research
Biomarker research
Radiation therapy
AML research
NEWS RELEASE
Off-the-shelf adoptive T-cell therapy
MD Anderson researchers led a Phase II trial validating adoptive T-cell therapy as an effective treatment option for progressive multifocal leukoencephalopathy (PML), a rare and often fatal brain infection sometimes observed in patients with cancer. The trial used donor T cells targeting a virus similar to the one that causes PML.
Personalizing Treatment
We're designing colorectal cancer vaccines specific for each patient